© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | Hans-Joachim Schmoll, MD, PhD
Articles
CHARTA Shows Survival Benefit of Four-Drug Regimen for Advanced CRC
January 21, 2017
This video examines results of the CHARTA trial, which tested first-line FOLFOX plus bevacizumab with or without irinotecan in patients with advanced colorectal cancer.